Merit Ester Cudkowicz, M.D.
Co-Author
This page shows the publications co-authored by Merit Cudkowicz and David Hafler.
Connection Strength
0.061
-
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study. Neurology. 2021 Dec 02.
Score: 0.061
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.